Ma-Mel-27Homo sapiens (Human)Cancer cell line

Also known as: MaMel27, Ma-Mel 27, Ma-Mel_27

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_A163
SpeciesHomo sapiens (Human)
Tissue SourceHypodermis[UBERON:UBERON_0002072]

Donor Information

Age58
Age CategoryAdult
SexFemale

Disease Information

DiseaseAcral lentiginous melanoma
LineageSkin
SubtypeMelanoma
OncoTree CodeMEL

DepMap Information

Source IDACH-001953_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleNRASp.Gly12Asp (c.35G>A)UnspecifiedSomaticWistar

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
8,11
D16S539
11,14
D3S1358
16,18
D5S818
12
D7S820
10,12
FGA
20,21
TH01
9.3
TPOX
8,11
vWA
17,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Mutual exclusivity analysis of genetic and epigenetic drivers in melanoma identifies a link between p14 ARF and RARbeta signaling.

Borg A., Pawelec G., Guldberg P.

Mol. Cancer Res. 11:1166-1178(2013).

TERT promoter mutations in familial and sporadic melanoma.";

Kadel S., Moll I., Nagore E., Hemminki K., Schadendorf D., Kumar R.

Science 339:959-961(2013).

Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.

Hemminki K., Schadendorf D., Kumar R.

Genes Chromosomes Cancer 49:733-745(2010).

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis.

Schadendorf D.

PLoS ONE 2:E236-E236(2007).

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

Dummer R.

Pigment Cell Res. 19:290-302(2006).